300347 泰格医药
已收盘 10-19 15:00:00
资讯
新帖
简况
泰格医药:公司实控人因信披违规被罚100万元
第一财经 · 10-16
泰格医药:公司实控人因信披违规被罚100万元
10月16日泰格医药现1笔大宗交易 机构净买入999.55万元
证券之星 · 10-16
10月16日泰格医药现1笔大宗交易 机构净买入999.55万元
股市必读:10月13日泰格医药现1笔大宗交易 机构净买入999.35万元
证券之星 · 10-14
股市必读:10月13日泰格医药现1笔大宗交易 机构净买入999.35万元
泰格医药(300347)披露向2026年A股限制性股票激励计划激励对象授予限制性股票的公告,10月12日股价上涨1.63%
证券之星 · 10-12
泰格医药(300347)披露向2026年A股限制性股票激励计划激励对象授予限制性股票的公告,10月12日股价上涨1.63%
泰格医药:第六届董事会第三次会议决议公告
证券日报 · 10-09
泰格医药:第六届董事会第三次会议决议公告
10月9日泰格医药现1笔大宗交易 机构净买入998.46万元
证券之星 · 10-09
10月9日泰格医药现1笔大宗交易 机构净买入998.46万元
泰格医药(300347)10月8日主力资金净卖出4212.02万元
证券之星 · 10-09
泰格医药(300347)10月8日主力资金净卖出4212.02万元
泰格医药最新公告:已耗资8.24亿元回购2096万股
证券之星 · 10-08
泰格医药最新公告:已耗资8.24亿元回购2096万股
泰格医药(03347):截至9月末累计回购2096.35万股A股
智通财经 · 10-08
泰格医药(03347):截至9月末累计回购2096.35万股A股
10月8日泰格医药跌5.02%,兴全商业模式LOF基金重仓该股
证券之星 · 10-08
10月8日泰格医药跌5.02%,兴全商业模式LOF基金重仓该股
泰格医药(300347)9月30日主力资金净买入5865.88万元
证券之星 · 10-08
泰格医药(300347)9月30日主力资金净买入5865.88万元
港股午评|恒生指数早盘跌0.04% CRO概念股涨幅居前
智通财经 · 09-30
港股午评|恒生指数早盘跌0.04% CRO概念股涨幅居前
港股异动 | 泰格医药(03347)盘中涨超4% 与迪安诊断签署战略合作协议 将围绕AI制药等多领域开展深度合作
智通财经 · 09-30
港股异动 | 泰格医药(03347)盘中涨超4% 与迪安诊断签署战略合作协议 将围绕AI制药等多领域开展深度合作
泰格医药(300347)披露2026年第三次临时股东会等会议决议公告,9月24日股价下跌2.89%
证券之星 · 09-24
泰格医药(300347)披露2026年第三次临时股东会等会议决议公告,9月24日股价下跌2.89%
摩根大通在泰格医药的H股好仓比例上升0.01%至20.63%
南方财经网 · 09-24
摩根大通在泰格医药的H股好仓比例上升0.01%至20.63%
研报掘金丨华源证券:首予泰格医药“增持”评级,领先的全球化临床CRO,多维赋能启新篇
格隆汇 · 09-23
研报掘金丨华源证券:首予泰格医药“增持”评级,领先的全球化临床CRO,多维赋能启新篇
泰格医药子公司方达医药顺利通过沙特SFDA现场核查
同花顺 · 09-21
泰格医药子公司方达医药顺利通过沙特SFDA现场核查
研报掘金丨平安证券:维持泰格医药“推荐”评级,订单增速回暖,股权激励提振信心
格隆汇 · 09-21
研报掘金丨平安证券:维持泰格医药“推荐”评级,订单增速回暖,股权激励提振信心
七年迟报权益变动引监管倒查,CRO 龙头主业回暖净利润却亏 4.13 亿元
华夏时报网 · 09-18
七年迟报权益变动引监管倒查,CRO 龙头主业回暖净利润却亏 4.13 亿元
Norges Bank减持泰格医药(03347)17.19万股 每股作价约43.75港元
智通财经 · 09-17
Norges Bank减持泰格医药(03347)17.19万股 每股作价约43.75港元
暂无数据
公司概况
公司名称:
杭州泰格医药科技股份有限公司
所属行业:
研究和试验发展
上市日期:
2012-08-17
主营业务:
杭州泰格医药科技股份有限公司的主营业务是临床CRO业务。公司的主要产品是临床试验技术服务、临床试验相关及实验室服务。
发行价格:
37.88
{"stockData":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":50.58,"timestamp":1792393425000,"preClose":50.07,"halted":0,"volume":9291776,"delay":0,"changeRate":0.0102,"floatShares":566000000,"shares":861000000,"eps":0.1062,"marketStatus":"已收盘","change":0.51,"latestTime":"10-19 15:00:00","open":49.49,"high":51.28,"low":48.07,"amount":462000000,"amplitude":0.0641,"askPrice":50.59,"askSize":33,"bidPrice":50.58,"bidSize":37,"shortable":0,"etf":0,"ttmEps":0.1062,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":5,"adr":0,"adjPreClose":50.07,"symbolType":"stock","openAndCloseTimeList":[[1792373400000,1792380600000],[1792386000000,1792393200000]],"highLimit":55.08,"lowLimit":45.06,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":861026050,"isCdr":false,"pbRate":2.21,"roa":"--","peRate":476.271186,"roe":"--","epsLYR":1.04,"committee":-0.122924,"marketValue":43551000000,"turnoverRate":0.0164,"status":0,"hkstockBrief":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":40.2,"timestamp":1792138096008,"preClose":41.66,"halted":0,"volume":1677866,"delay":0,"premium":"-32.32"},"floatMarketCap":28652000000},"requestUrl":"/m/hq/s/300347/tweets","defaultTab":"tweets","newsList":[{"id":"2675594273","title":"泰格医药:公司实控人因信披违规被罚100万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675594273","media":"第一财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675594273?lang=zh_cn&edition=full","pubTime":"2026-10-16 20:15","pubTimestamp":1792152946,"startTime":"0","endTime":"0","summary":"【泰格医药:公司实控人因信披违规被罚100万元】泰格医药公告称,公司实际控制人叶小平、曹晓春收到证监会浙江监管局出具的《行政处罚决定书》,因2019年9月20日合计持有公司有表决权股份比例累计变动达5%时未及时披露《简式权益变动报告书》,迟至2026年5月12日补充披露,构成信息披露违法行为。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610163898566154.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610163898566154.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1820825898.SGD","BK1141","300347","03347","BK0174","BK0216","LU1146622755.USD","BK0028","BK1583","BK1576","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675560788","title":"10月16日泰格医药现1笔大宗交易 机构净买入999.55万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675560788","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675560788?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:22","pubTimestamp":1792142531,"startTime":"0","endTime":"0","summary":"证券之星消息,10月16日泰格医药发生大宗交易,交易数据如下:大宗交易成交价格52.06元,相对当日收盘价溢价3.97%,成交19.2万股,成交金额999.55万元,买方营业部为机构专用,卖方营业部为广发证券股份有限公司佛山灯湖东路证券营业部。近三个月该股共发生6笔大宗交易,合计成交1.07万手,溢价成交5笔。截至2026年10月16日收盘,泰格医药报收于50.07元,下跌3.82%,换手率2.22%,成交量12.54万手,成交额6.54亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600029218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK0077","03347","LU1146622755.USD","300347","BK1583","BK0216","BK0174","LU1820825898.SGD","BK0028","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675667013","title":"股市必读:10月13日泰格医药现1笔大宗交易 机构净买入999.35万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675667013","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675667013?lang=zh_cn&edition=full","pubTime":"2026-10-14 00:54","pubTimestamp":1791910450,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘,泰格医药报收于54.32元,下跌3.14%,换手率1.7%,成交量9.61万手,成交额5.23亿元。当日关注点交易信息汇总:10月13日主力资金净流入2179.85万元,占总成交额4.17%; 交易信息汇总:当日发生1笔大宗交易,机构净买入999.35万元。大宗交易10月13日泰格医药发生1笔大宗交易,机构净买入999.35万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400001152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0174","BK1576","BK1583","LU1820825898.SGD","300347","03347","BK0216","LU1146622755.USD","BK1141","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674687524","title":"泰格医药(300347)披露向2026年A股限制性股票激励计划激励对象授予限制性股票的公告,10月12日股价上涨1.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674687524","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674687524?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:36","pubTimestamp":1791797805,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘,泰格医药报收于56.08元,较前一交易日上涨1.63%,最新总市值为482.86亿元。该股当日开盘55.01元,最高58.27元,最低55.0元,成交额达6.46亿元,换手率为2.01%。近日,杭州泰格医药科技股份有限公司发布《关于向2026年A股限制性股票激励计划激励对象授予限制性股票的公告》。公告显示,公司于2026年10月9日向498名激励对象授予917.477万股第二类限制性股票,授予价格为39.32元/股。股份支付费用将在2026年至2029年间摊销,预计总费用为11,790.44万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200023399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02846","BK1147","LU1146622755.USD","02827","03347","82823","02843","07233","300347","BK0216","83188","83130","BK1141","03188","82843","82846","BK1576","BK0077","399300","BK0028","BK1583","02822","03130","82822","BK1610","LU1820825898.SGD","02823","BK0174","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674885495","title":"泰格医药:第六届董事会第三次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2674885495","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674885495?lang=zh_cn&edition=full","pubTime":"2026-10-09 20:21","pubTimestamp":1791548460,"startTime":"0","endTime":"0","summary":"证券日报网讯10月9日,泰格医药发布公告称,公司于2026年10月9日召开第六届董事会第三次会议,审议通过《关于调整2026年A股限制性股票激励计划激励对象名单及授予权益数量的议案》《关于向2026年A股限制性股票激励计划激励对象授予限制性股票的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610093891446052.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610093891446052.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["300347","LU1146622755.USD","BK0216","BK0077","LU1820825898.SGD","03347","BK1583","BK1576","BK0174","BK1141","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674683034","title":"10月9日泰格医药现1笔大宗交易 机构净买入998.46万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674683034","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674683034?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:28","pubTimestamp":1791538127,"startTime":"0","endTime":"0","summary":"证券之星消息,10月9日泰格医药发生大宗交易,交易数据如下:大宗交易成交价格55.47元,相对当日收盘价溢价0.53%,成交18万股,成交金额998.46万元,买方营业部为机构专用,卖方营业部为广发证券股份有限公司佛山灯湖东路证券营业部。近三个月该股共发生4笔大宗交易,合计成交6960.0手,溢价成交3笔。截至2026年10月9日收盘,泰格医药报收于55.18元,下跌0.52%,换手率1.99%,成交量11.28万手,成交额6.11亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900026934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK0077","03347","BK1576","BK0174","BK0028","BK1583","LU1146622755.USD","BK0216","LU1820825898.SGD","300347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674817638","title":"泰格医药(300347)10月8日主力资金净卖出4212.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674817638","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674817638?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:16","pubTimestamp":1791508609,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月8日收盘,泰格医药报收于55.47元,下跌5.02%,换手率2.19%,成交量12.39万手,成交额7.0亿元。近5日资金流向一览见下表:泰格医药融资融券信息显示,融资方面,当日融资买入4845.04万元,融资偿还5446.25万元,融资净偿还601.22万元。泰格医药主营业务:临床试验技术服务和临床试验相关服务及实验室服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900007290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0174","BK1576","BK1583","LU1820825898.SGD","300347","03347","BK0216","LU1146622755.USD","BK1141","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673078114","title":"泰格医药最新公告:已耗资8.24亿元回购2096万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673078114","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673078114?lang=zh_cn&edition=full","pubTime":"2026-10-08 17:37","pubTimestamp":1791452265,"startTime":"0","endTime":"0","summary":"泰格医药(300347.SZ)公告称,截至2026年9月30日,公司通过集中竞价方式累计回购股份2096.35万股,占总股本的2.4347%,成交总金额为8.24亿元。回购价格区间为38.22元/股至42.78元/股,符合回购方案要求。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。相关 ETF","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800022852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK1141","03347","BK0216","BK1576","BK0028","300347","BK0174","BK1583","LU1820825898.SGD","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673020989","title":"泰格医药(03347):截至9月末累计回购2096.35万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673020989","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673020989?lang=zh_cn&edition=full","pubTime":"2026-10-08 17:08","pubTimestamp":1791450512,"startTime":"0","endTime":"0","summary":"智通财经APP讯,泰格医药(03347)发布公告,截至2026年9月30日,公司通过股份回购专用证券账户以集中竞价交易方式回购公司股份2096.35万股,占公司目前总股本的2.4347%,占公司目前A股总股本的2.8410%。最高成交价为42.78元/股,最低成交价为38.22元/股,成交总金额为8.24亿元(不含交易费用)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504639.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["83188","BK1147","BK1576","03347","BK1583","02846","82822","82843","02827","03130","300347","07233","LU1820825898.SGD","BK0028","02823","BK0174","BK0077","BK1610","159982","02822","83130","BK1141","03188","82823","02843","BK0216","82846","399300","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673027130","title":"10月8日泰格医药跌5.02%,兴全商业模式LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673027130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673027130?lang=zh_cn&edition=full","pubTime":"2026-10-08 16:46","pubTimestamp":1791449185,"startTime":"0","endTime":"0","summary":"证券之星消息,10月8日泰格医药跌5.02%,收盘报55.47元,换手率2.19%,成交量12.39万手,成交额7.0亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共85家,其中持有数量最多的公募基金为兴证全球基金的兴全商业模式LOF。兴全商业模式LOF的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800021459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","BK0174","BK0216","BK1583","BK1141","LU1146622755.USD","BK0028","BK0077","300347","BK1576","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673497220","title":"泰格医药(300347)9月30日主力资金净买入5865.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673497220","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673497220?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:06","pubTimestamp":1791421562,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月30日收盘,泰格医药报收于58.4元,上涨3.42%,换手率2.52%,成交量14.24万手,成交额8.32亿元。近5日资金流向一览见下表:泰格医药融资融券信息显示,融资方面,当日融资买入8094.27万元,融资偿还8461.71万元,融资净偿还367.44万元。泰格医药主营业务:临床试验技术服务和临床试验相关服务及实验室服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800002965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","03347","BK0216","300347","BK1141","BK1576","BK0028","BK0174","BK1583","BK0077","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671222053","title":"港股午评|恒生指数早盘跌0.04% CRO概念股涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222053","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671222053?lang=zh_cn&edition=full","pubTime":"2026-09-30 12:00","pubTimestamp":1790740842,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,港股恒生指数跌0.04%,跌10个点,报24513点;恒生科技指数跌0.15%。港股早盘成交887亿港元。mRNA概念股涨幅居前。CRO概念股涨幅居前,BD高增叠加湿实验需求升温,行业景气度上行信号明确。泰格医药涨超4%,与迪安诊断签署战略合作协议,将围绕AI制药等多领域开展深度合作。地产港股盘中V型反转,万科企业一度跌超11%,午盘涨超2%。汇量科技涨超8%,AI Infra升级有望进一步提升算法效率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502511.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","HHImain","BK4551","BK1524","09115","603127","03417","BK1178","LU0244354667.USD","BK4533","MCHmain","URNJ","03423","BK1594","BK4585","HK0000320264.USD","LU0326950275.SGD","HK0000320223.HKD","BK1574","03033","BK1515","HSTECH","03037","BK1161","MRNX","03067","01548","06821","02202","BK1198","BK1583","HK0000306701.USD","01787","000002","07226","07200","MRNA","002821","07552","LU0828237940.HKD","02362","LU0140636845.USD","01860","BK4588","03419","BK1544","02833","300347","02723","03347","BK4568","06185","MRNY","IE0034224299.USD","688185","BK1590","BK1521","BK4139","03032","09088","GNOM","BK4501","HSI","BK1518","BK1576","BK1613","HK0000306685.HKD","06802","01164","513600","07500","00625","02837","BK4532","83115","06127","09067","82800","LU0181495838.USD","BK4534","LU1831875114.USD","BK1206","07300","02800","03115","BK1555","LU0463099449.HKD","BK1592","LU1188198961.HKD","WDNA","BK1137","BK1191","BK4548","BK1586","LGHT","600547","IDNA","BK1240","BK1507","03088"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671221261","title":"港股异动 | 泰格医药(03347)盘中涨超4% 与迪安诊断签署战略合作协议 将围绕AI制药等多领域开展深度合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2671221261","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671221261?lang=zh_cn&edition=full","pubTime":"2026-09-30 10:13","pubTimestamp":1790734418,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,泰格医药盘中涨超4%,截至发稿,涨3.63%,报47港元,成交额1976.94万港元。消息面上,据泰格医药官微消息,近日,泰格医药与迪安诊断在杭州签署战略合作协议。双方将围绕AI制药、临床试验、伴随诊断等领域开展深度合作,共同构建国内领先的“创新药研发—伴随诊断”一体化协同体系,让诊断与数据能力更早融入药物研发过程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502477.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK0236","LU1820825898.SGD","CHAT","03347","BK0174","BK0197","BK0146","300347","BK1141","BK1583","BK4588","BK0028","BK0077","KCAI","LU1146622755.USD","BK1576","VTHR","BK1191","ARTY","BK0216","BK0070","BK0042","AGIX","BK1574","AIPO","BK0114","01477","VXUS","300244","QTOC","BK0186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669469864","title":"泰格医药(300347)披露2026年第三次临时股东会等会议决议公告,9月24日股价下跌2.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669469864","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669469864?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:36","pubTimestamp":1790242580,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘,泰格医药报收于56.81元,较前一交易日下跌2.89%,最新总市值为489.15亿元。公司于近日披露《2026年第三次临时股东会、2026年第三次A股类别股东会议及2026年第三次H股类别股东会议决议的公告》。会议表决结果合法有效,无否决议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400030384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","BK1141","300347","03347","BK0174","BK0216","LU1146622755.USD","BK0028","BK1583","BK1576","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669466136","title":"摩根大通在泰格医药的H股好仓比例上升0.01%至20.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669466136","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669466136?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:18","pubTimestamp":1790241480,"startTime":"0","endTime":"0","summary":"南财智讯9月24日电,香港交易所披露信息显示,JPMorganChase&Co.(摩根大通)在泰格医药的H股好仓(L)比例于9月21日从20.62%上升至20.63%。同时淡仓(S)比例从0.73%升至0.76%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609243883773851.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609243883773851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["300347","LU1146622755.USD","BK0216","BK0077","PGF","BK4582","LU1820825898.SGD","03347","BK1583","BK1576","BK0174","BK1141","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669106677","title":"研报掘金丨华源证券:首予泰格医药“增持”评级,领先的全球化临床CRO,多维赋能启新篇","url":"https://stock-news.laohu8.com/highlight/detail?id=2669106677","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669106677?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:01","pubTimestamp":1790150503,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0028","BK0077","161027","BK0216","BK0174","LU1820825898.SGD","300347","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150983","title":"泰格医药子公司方达医药顺利通过沙特SFDA现场核查","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150983","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669150983?lang=zh_cn&edition=full","pubTime":"2026-09-21 18:51","pubTimestamp":1789987860,"startTime":"0","endTime":"0","summary":"近日,由方达医药提供临床运营及生物分析一体化全包服务的一项肿瘤药物临床研究,顺利通过沙特食品药品监督管理局(Saudi Food and Drug Authority,SFDA)现场核查,为产品海外注册及市场拓展 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260921/c680134776.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260921/c680134776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["159938","LU1820825898.SGD","BK0174","BK0077","BK1583","BK1161","BK1574","BK1576","LU1146622755.USD","09939","BK1515","03347","BK0216","BK0028","300347","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669137082","title":"研报掘金丨平安证券:维持泰格医药“推荐”评级,订单增速回暖,股权激励提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2669137082","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669137082?lang=zh_cn&edition=full","pubTime":"2026-09-21 13:56","pubTimestamp":1789970213,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["161027","LU1820825898.SGD","300347","BK0174","BK0028","BK0216","LU1146622755.USD","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668117179","title":"七年迟报权益变动引监管倒查,CRO 龙头主业回暖净利润却亏 4.13 亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2668117179","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668117179?lang=zh_cn&edition=full","pubTime":"2026-09-18 10:53","pubTimestamp":1789699985,"startTime":"0","endTime":"0","summary":"2026年9月,国内临床CRO龙头泰格医药(300347.SZ/03347.HK)公告,公司实际控制人叶小平、曹晓春因两起历史持股变动未及时披露收到监管文件。其中2019年9月的一起被认定构成信息披露违法,拟对二人给予警告并合计罚款100万元、各承担50万元;2022年12月的一起则被出具警示函并记入诚信档案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609183878421992.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609183878421992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","BK1141","BK0028","BK0174","BK0077","300347","LU1820825898.SGD","BK0216","03347","BK1583","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668765961","title":"Norges Bank减持泰格医药(03347)17.19万股 每股作价约43.75港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2668765961","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668765961?lang=zh_cn&edition=full","pubTime":"2026-09-17 19:35","pubTimestamp":1789644919,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,9月15日,Norges Bank减持泰格医药(03347)17.19万股,每股作价43.7462港元,总金额约为751.997万港元。减持后最新持股数目约为722.53万股,最新持股比例为5.87%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BK1583","EWH","BK1141","BK0077","BK0028","300347","BK0216","BK0174","ENOR","LU1820825898.SGD","03347","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792449621176,"stockEarnings":[{"period":"1week","weight":-0.0981},{"period":"1month","weight":-0.1187},{"period":"3month","weight":0.008},{"period":"6month","weight":-0.1162},{"period":"1year","weight":-0.0532},{"period":"ytd","weight":-0.1054}],"compareEarnings":[{"period":"1week","weight":-0.0175},{"period":"1month","weight":-0.0463},{"period":"3month","weight":-0.0345},{"period":"6month","weight":-0.0914},{"period":"1year","weight":-0.0283},{"period":"ytd","weight":-0.0599}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州泰格医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"0人","perCapita":"--","listingDate":"2012-08-17","address":"浙江省杭州市滨江区浦沿街道陆家潭街508号6层601-610室","registeredCapital":"86102万元","survey":" 杭州泰格医药科技股份有限公司的主营业务是临床CRO业务。公司的主要产品是临床试验技术服务、临床试验相关及实验室服务。","listedPrice":37.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(300347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(300347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,300347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(300347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(300347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}